Occurrence of aminoglycoside-modifying enzymes and β-lactamases in Acinetobacter spp., isolated from different hospitals in Bratislava

Biologia - Section Cellular and Molecular Biology

Volumn 58, Issue 6, 2003, Pages 1087-1094

  Vrábelová, Miroslava ^a   Černická, Jana ^a   Kvačkajová, Jana ^a   Michálková Papajová, Dana ^a   Milošovič, Peter ^b   Rovná, Daniela ^c   Perďochova, L'ubica ^c   Mačičková, Tatiana ^d   Benczeová, Silvia ^a   Kettner, Milan ^a  

^a Physics and Informatics   (Slovakia)

^b State Public Health Institute of the Slovak Republic   (Slovakia)

^c Department of Surgery   (Slovakia)

^d INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

lactam resistance; Acinetobacter sp.; Aminoglycoside resistance; R plasmids

Indexed keywords

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER SP.;

EID: 0346936356     PISSN: 13356399     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. BAUERFEIND, A., MILLER, G. H. & THE AMINOGLYCOSIDE RESISTANCE STUDY GROUPS. 1994. Assessment of aminoglycoside resistance mechanisms from 1989 to 1993 in Acinetobacter sp. Abstr. Internat. Symp. Enhancing Traditional Aminoglycoside Therapy, Tylney Hall, Great Britain, Sept. 23-25, p. 7.
2. BERGOGNE-BÉRÉZIN, E. 1994. Acinetobacter spp., saprophytic organisms of increasing pathogenic importance. Zbl. Bakt. 281: 389-405.
3. BERGOGNE-BÉRÉZIN, E. 2001. The increasing role of Acinetobacter species as nosocomial pathogens. Curr. Infect. Dis. Rep. 3: 440-445.
4. GALES, A. C., JONES, R. N., FORWARD, K. R., LINARES, J., SADER, H. S. & VERHOEF, J. 2001. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program. Clin. Infect. Dis. 32: 104-108.
5. HANBERGER, H., DIEKEMA, D., FLUIT, A., JONES, R., STRUELENS, M., SPENCER, R. & WOLFF, M. 2001. Surveillance of antibiotic resistance in European ICUs. J. Hosp. Infect. 48: 161-166.
6. JARLIER, V., NICOLAS, M., FOURNIER, G. & PHILIPPON, A. 1998. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10: 867-878.
7. JEAN, S. S., TENG, L. J., HSUEH, P. R., HO, S. W. & LUH, K. T. 2002. Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Gram-negative bacteria in a Taiwanese University Hospital. J. Antimicrob. Chemother. 49: 69-75.
8. JOLY-GUILLOU, M. L., DECRÉ, D., HERRMAN, J. L., BOURDELIER, E. & BERGOGNE-BÉRÉZIN, E. 1995. Bactericidal in vitro activity of β-lactams and β-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: effect of combination with aminoglycosides. J. Antimicrob. Chemother. 36: 619-629.
9. KETTNER, M., NAVAROVÁ, J., RÝDL, Z., KNOTHE, H., LEBEK, G. & KRČMÉRY, V. 1981. Occurrence of aminoglycoside-modifying enzymes in resistant strains of enterobacteria and Pseudomonas aeruginosa from several countries. J. Antimicrob. Chemother. 8: 175-183.
10. LEE, K., LEE, H. S., JANG, S. J., PARK, A. J., LEE, M. H., SONG, W. K. & CHONG, Y. Members of Korea Nationwide Surveillance of Antimicrobial Resistance Group 2001. Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vankomycin and Gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone. J. Korean Med. Sci. 16: 262-268.
11. LYYTIKäINEN, O., KÖLJALG, S., HÄRMÄ, M. & VUOPIO-VARKILA, J. 1995. Outbreak caused by two multi-resistant Acinetobacter clones in a burn unit: emergence of resistance to imipenem. J. Hosp. Infect. 31: 41-54.
12. th ed. Approved Standard M7-A5, PA, USA.
13. ONARHEIM, H., HOIVIK, T., HARTHUG, S., DIGRANES, A., MYLVAGANAN, H. & GINDENES, H. A. 2000. Outbreak of multiresistant Acinetobacter baumannii infection. Tidsskr. Nor. Laegeforen 120: 1028-1033.
14. ROBERTS, S. A., FINDLAY, R. & LANG, S. D. 2001. Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit. J. Hosp. Infect. 48: 228-233.
15. SEWARD, R. J., LAMBERT, T. & TOWNER, K. J. 1998. Molecular epidemiology of aminoglycoside resistance in Acinetobacter spp. J. Med. Microbiol. 47: 455-462.
16. SHAW, K. J., RATHER, P. N., HARE, R. S. & MILLER, G. H. 1993. Molecular genetics of aminoglycoside resistance genes and familiar relationships of the aminoglycoside-modifying enzymes. Microbiol. Rev. 57: 138-163.
17. SONG, W., LEE, K. M., KANG, H. J., SHIN, D. H. & KIM, D. K. 2001. Microbiologic aspects of predominant bacteria isolated from the burn patients in Korea. Burns 27: 136-140.
18. STAPLETON, P., WU, P. S., KING, A., SHANNON, K., FRENCH, G. & PHILLIPS, I. 1995. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob. Agents Chemother. 39: 2478-2483.
19. TAKAHASHI, S. & NAGANO, Y. 1984. Rapid procedure for isolation of plasmid DNA and application to epidemiological analysis. J. Clin. Microbiol. 20: 608-613.
20. VILA, J., NAVIA, M., RUIZ, J. & CASALS, C. 1997. Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived β-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 41: 2757-2759.